SECURITIES AND EXCHANGE COMMISSIONTable of Contents • December 7th, 2019
Contract Type FiledDecember 7th, 2019The following documents filed by BioCryst Pharmaceuticals, Inc. (the “Registrant”) with the Securities and Exchange Commission (the “Commission”) pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”) are incorporated by reference in this Registration Statement: